GLP-1 receptor agonist shortage expected to continue for all of 2024
In a national patient safety alert, the Department of Health and Social Care advised switching patients on Byetta and Victoza to Rybelsus, and to provide appropriate counselling with any changes.…
Published: 4 January 2024